OLBERON MEDICAL
www.olberon.com
eis
Please note that this pitch has now closed.
Tab
here10EIS Only
Offer Information
Min Max
Investment Target £100,000 £250,000
Share Price £9.50 £9.50
Shares Offered info 10,526 26,316
Percentage Offered info 6.67% 15.15%
Shares Issued info 147,400
Pre-money Valuation £1,400,300
Share Type Ordinary
Minimum Investment £28.50
Tax Relief Available EIS
Sector Healthcare & Pharmaceuticals
Inventions
Location Nottingham, United Kingdom
Company Number 05480127
OLBERON MEDICAL
Olberon is a medical device innovations company specialising in venous access & diagnostic devices. Seeking to raise funds for the manufacture & sale of Vacuderm, a device to assist with childrens' cannulation procedure.
About OLBERON MEDICAL

Olberon Ltd, a UK based medical innovations company, has built up a strong portfolio of in-house patented medical innovations, two medical devices that are market ready from concept to commercialisation, as well as offering consultancy services to both the NHS and the wider medical device market.

Olberon is now seeking up to £250,000 to launch development of the childrens' Vacuderm and grow sales distribution networks in both the UK and internationally for its commercial ready medical devices. Vacuderm is designed to help reduce failure rates in cannulation procedures in children.

Image of Vacuderm

Revenue

The company has to date been funded mainly through consultancy services provided by Dr Arash Bakhtyari and from grants received from The University of Derby and other grant funds applied for future.

Market

The global medical device market is expected to reach $343 billion by 2021, with growth forecast at 5% per annum from 2016 to 2021 (Lucintel, September 2016). The main drivers advancing growth are increased healthcare expenditure, increase in health awareness and ageing populations. The medical device industry is one of the biggest industries in healthcare and has seen growth catalysed by medical innovations and improved technology.

Olberon's Vacuderm is designed to assist with a global medical problem (inserting a hollow tube into the vein - cannulation) this procedure has a high first time failure rate of 30%. Currently there are 859 million cannula used worldwide, with a cost per procedure of £32.61 per patient (UK Pricing).

Fully developed venous access novel products have shown to have significant market value. Venetech developing Statlock, a cannula securement device was bought by Bard for $166 million in 2006. Retractable Technologies Inc won a patent infringement suit for a self retracting syringe (Vanishpoint) against BD for $340 million.

Vacuderm

Olberon has also developed the Otorhinoscope, a diagnostic device which is a dual purpose ear and nose examination device with a single unique expandable speculum, that addresses several issues and improves pathology detection for GP's, ENT's and emergency departments, while saving time and money.

The UK market size for the Otorhinoscope is estimated at 58,500 units per annum. The Otorhinoscope's competition would be the Otoscope market, however the Otorhinoscope offers a solution to a common problem experienced by general practitioners in that they do not have a simple device to examine the nasal cavities with so we are offering an Otoscope that can do this, giving the device a competitive edge.

Tax Relief

Olberon Ltd has achieved advanced assurance for the Enterprise Investment Scheme (EIS). We believe this could prove an interesting investment while helping Olberon to enable healthcare providers to reduce costs and help patients not to suffer as much during medical procedures.




To find out more about this pitch or to ask the Director(s) a question please Join Now or Log in below

Join
Log in


Why join Crowd for Angels?

arrowRegister in minutes

arrowNo fees for Investors

arrowInvest from £25

arrowAccess your portfolio 24/7

Why invest in UK businesses

Discover investment opportunities, support companies you believe in and share their success Take advantage of SEIS/EIS tax relief to minimize your tax and the opportunity to obtain high-interest rates.


About Crowd for Angels

With us, you can gain access to great UK companies offering Shares, Crowd Bonds or Digitalised Assets through our easy to use online platform.

Management Team



To find out more about this pitch or to ask the Director(s) a question please Join Now or Log in below

Join
Log in


Why join Crowd for Angels?

arrowRegister in minutes

arrowNo fees for Investors

arrowInvest from £25

arrowAccess your portfolio 24/7

Why invest in UK businesses

Discover investment opportunities, support companies you believe in and share their success Take advantage of SEIS/EIS tax relief to minimize your tax and the opportunity to obtain high-interest rates.


About Crowd for Angels

With us, you can gain access to great UK companies offering Shares, Crowd Bonds or Digitalised Assets through our easy to use online platform.

Documents



To find out more about this pitch or to ask the Director(s) a question please Join Now or Log in below

Join
Log in


Why join Crowd for Angels?

arrowRegister in minutes

arrowNo fees for Investors

arrowInvest from £25

arrowAccess your portfolio 24/7

Why invest in UK businesses

Discover investment opportunities, support companies you believe in and share their success Take advantage of SEIS/EIS tax relief to minimize your tax and the opportunity to obtain high-interest rates.


About Crowd for Angels

With us, you can gain access to great UK companies offering Shares, Crowd Bonds or Digitalised Assets through our easy to use online platform.

Updates



To find out more about this pitch or to ask the Director(s) a question please Join Now or Log in below

Join
Log in


Why join Crowd for Angels?

arrowRegister in minutes

arrowNo fees for Investors

arrowInvest from £25

arrowAccess your portfolio 24/7

Why invest in UK businesses

Discover investment opportunities, support companies you believe in and share their success Take advantage of SEIS/EIS tax relief to minimize your tax and the opportunity to obtain high-interest rates.


About Crowd for Angels

With us, you can gain access to great UK companies offering Shares, Crowd Bonds or Digitalised Assets through our easy to use online platform.

Rewards



To find out more about this pitch or to ask the Director(s) a question please Join Now or Log in below

Join
Log in


Why join Crowd for Angels?

arrowRegister in minutes

arrowNo fees for Investors

arrowInvest from £25

arrowAccess your portfolio 24/7

Why invest in UK businesses

Discover investment opportunities, support companies you believe in and share their success Take advantage of SEIS/EIS tax relief to minimize your tax and the opportunity to obtain high-interest rates.


About Crowd for Angels

With us, you can gain access to great UK companies offering Shares, Crowd Bonds or Digitalised Assets through our easy to use online platform.

Offer Information
Min Max
Investment Target £100,000 £250,000
Share Price £9.50 £9.50
Shares Offered info 10,526 26,316
Percentage Offered info 6.67% 15.15%
Shares Issued info 147,400
Pre-money Valuation £1,400,300
Share Type Ordinary
Minimum Investment £28.50
Tax Relief Available EIS
Sector Healthcare & Pharmaceuticals
Inventions
Location Nottingham, United Kingdom
Company Number 05480127

To read the full OLBERON MEDICAL pitch, please join.
It is free, quick and easy.

Join Now

Already registered? Log in

Risk Warning

Investing in small public listed or private companies involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Investing in debt pitches through Crowd for Angels (UK) Limited involves lending to companies and therefore your capital is at risk and interest payments are not guaranteed if the borrower defaults. Investments on this website are targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own Investment Decisions. You will only be able to invest in pitches on this website once you are authorised. Please click here to read the full Risk Warning.

This page has been approved as a Financial Promotion by Crowd for Angels (UK) Limited (Company number: 03064807) , which is authorised and regulated by the Financial Conduct Authority (Reference number: 176508). Investments can only be made on the basis of information provided in the Pitches by the Investee Companies concerned. Crowd for Angels takes no responsibility for this Information or for any recommendations or opinions made by the Investee Companies.

Pitches may contain forward looking statements and financial forecasts or projections. Forecasts are not a reliable indicator of future performance. Crowd For Angels makes no judgement or opinion of the likelihood of targets being achieved. Investments made in companies listed on the Crowd For Angels platform are not covered by the Financial Services Compensation Scheme (FSCS).

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.